(Verbatim from the application): Brief episodes of sublethal ischemia render the myocardium more resistant against subsequent sustained ischemia and reperfusion: a phenomenon called ischemic preconditioning (PC). The infarct limiting effect of PC is transient, disappearing in 2-3 hrs. However, PC reappears 24 hrs after the initial stimulus, a phenomenon termed as delayed protection. PC occurs following activation of a number of G protein coupled receptors including adenosine (A1 or A3 subtypes), alpha adrenergic, delta1-opioid, free radicals (nitric oxide) and proposed effectors such as the KATP channel openers. While the agonists of these receptors, free radicals as well as KATP channel openers produce immediate (acute) cardioprotective effect, we do not know whether all of them produce delayed protection also. Our goal is to fully characterize the delayed response of these pharmacological trigger(s) and effectors of PC and to understand the complex signal transduction mechanism(s) of late myocardial protection. Our first hypothesis is that pharmacological triggers and effectors of PC induce delayed myocardial protection via nitric oxide (NO)-dependent pathway. We will study the delayed protection by agonists of the receptors (adenosine A1/A3, alpha adrenergic, delta1-opioid,), free radicals and KATP channel openers (diazoxide, pinacidil) in reducing myocardial infarction and apoptosis in the rabbit heart. Role of NO synthase(s) in mediating the delayed protection would be determined by pharmacological inhibition and gene knockout mice. Our second hypothesis is that pharmacological triggers of PC activate signaling pathway leading to phosphorylation of p38, p44 and p42 MAP kinases and also cause their translocation in the nucleus. The third hypothesis is that pharmacological triggers cause activation of nuclear factor kB (NF-kB) via MAP-kinase signaling pathway in the heart. We will show that the pharmacological triggers activate MAP-kinase signaling, that leads to proteolytic degradation of IkB-, release and translocation of NF-kB to the nucleus. Our fourth hypothesis is that activation of NFkB by pharmacological triggers lead to the expression of stress proteins MnSOD, iNOS and Bcl-2 and inhibition of apoptosis. Our fifth hypothesis is that KATP channel openers induce early and delayed ischemic protection via MAP kinase signaling pathway in the heart. These studies will help us learn a great deal on the endogenous mechanisms of delayed preconditioning and assist us in developing innovative techniques leading to one of the most effective means of salvaging ischemic myocardium.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL051045-08
Application #
6638358
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Program Officer
Balshaw, David M
Project Start
1995-08-01
Project End
2005-04-30
Budget Start
2003-05-01
Budget End
2004-04-30
Support Year
8
Fiscal Year
2003
Total Cost
$290,000
Indirect Cost
Name
Virginia Commonwealth University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
105300446
City
Richmond
State
VA
Country
United States
Zip Code
23298
Nagiub, Mohamed; Filippone, Scott; Durrant, David et al. (2017) Long-acting PDE5 inhibitor tadalafil prevents early doxorubicin-induced left ventricle diastolic dysfunction in juvenile mice: potential role of cytoskeletal proteins. Can J Physiol Pharmacol 95:295-304
Kura, B; Yin, C; Frimmel, K et al. (2016) Changes of microRNA-1, -15b and -21 levels in irradiated rat hearts after treatment with potentially radioprotective drugs. Physiol Res 65 Suppl 1:S129-37
Das, Sayantanee; Filippone, Scott M; Williams, Denise S et al. (2016) Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells. Mol Cell Biochem 421:89-101
Das, Anindita; Durrant, David; Mitchell, Clint et al. (2016) Sildenafil (Viagra) sensitizes prostate cancer cells to doxorubicin-mediated apoptosis through CD95. Oncotarget 7:4399-413
Gill, Rabia; Kuriakose, Robin; Gertz, Zachary M et al. (2015) Remote ischemic preconditioning for myocardial protection: update on mechanisms and clinical relevance. Mol Cell Biochem 402:41-9
Das, Anindita; Samidurai, Arun; Hoke, Nicholas N et al. (2015) Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-I?. Basic Res Cardiol 110:42
Salloum, Fadi N; Sturz, Gregory R; Yin, Chang et al. (2015) Beetroot juice reduces infarct size and improves cardiac function following ischemia-reperfusion injury: Possible involvement of endogenous H2S. Exp Biol Med (Maywood) 240:669-81
Das, Anindita; Salloum, Fadi N; Filippone, Scott M et al. (2015) Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling. Basic Res Cardiol 110:31
Koka, Saisudha; Aluri, Hema S; Xi, Lei et al. (2014) Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1? signaling. Am J Physiol Heart Circ Physiol 306:H1558-68
Salloum, Fadi N; Chau, Vinh Q; Hoke, Nicholas N et al. (2014) Tadalafil prevents acute heart failure with reduced ejection fraction in mice. Cardiovasc Drugs Ther 28:493-500

Showing the most recent 10 out of 110 publications